HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Mittermueller Selected Research

Drug Therapy (Chemotherapy)

9/2004Genetic analyses permit the differentiation between reactive malfunctions ('promyelocyte arrest') and arising promyelocyte leukemia in a pregnant patient with a history of a medulloblastoma.
10/2001Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Mittermueller Research Topics

Disease

2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2001 - 01/2000
2Lymphoid Leukemia
10/2001 - 01/2000
1Sepsis (Septicemia)
09/2004
1Leukemia
09/2004
1Lymphatic Metastasis
09/2004
1Medulloblastoma
09/2004
1Pancytopenia
09/2004
1Pathologic Complete Response
10/2001

Drug/Important Bio-Agent (IBA)

2Immunoglobulins (Immunoglobulin)IBA
10/2001 - 01/2000
2Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
10/2001 - 01/2000
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2001 - 01/2000
2CytokinesIBA
10/2001 - 01/2000
1DNA (Deoxyribonucleic Acid)IBA
10/2001
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2000
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
09/2004 - 10/2001
1Combination Drug Therapy (Combination Chemotherapy)
09/2004
1Radiotherapy
09/2004